This filing is a routine administrative extension of existing credit lines with no new debt raised or material terms changed. Preferred shareholders should monitor the next quarterly filing for any changes in leverage or coverage ratios, but this event alone has no immediate trading implications.
Price Chart
Executive Summary
CHS Inc. amended two existing financing facilities on August 26, 2026: its receivables and loans securitization facility (under the Receivables Purchase Agreement) and its repurchase financing facility (under the Framework Agreement). Both amendments primarily extend the scheduled termination dates to August 25, 2027, and include administrative changes and pricing revisions (including removal of a credit spread adjustment on the securitization facility). This is a routine refinancing/extension of existing credit lines with no new borrowing amounts disclosed, representing a neutral administrative event for preferred shareholders.
Key Financial Metrics
Key Facts
- CHS amended its receivables and loans securitization facility (Receivables Purchase Agreement) to extend the term to August 25, 2027.
- CHS amended its repurchase financing facility (Framework Agreement) to extend the scheduled term to August 25, 2027.
- Pricing revisions on the securitization facility include removal of the credit spread adjustment.
- No new principal amounts, interest rates, or material changes to covenants were disclosed.
- Both amendments were entered into on August 26, 2026, and are routine extensions of existing credit facilities.
Financial Impact
Routine extension of two existing credit facilities with no new borrowing amounts disclosed. Pricing revisions on the securitization facility (removal of credit spread adjustment) may modestly reduce financing costs, but no dollar figures were provided.
Risk Factors
- No material risks identified from this filing; the extensions are routine and do not signal distress.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000823277-26-000029 |
| Document: 0000823277-26-000029-index.html | 0000823277-26-000029 |
| Document: 0000823277-26-000029.txt | 0000823277-26-000029 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 22d ago | 8-K | $26.09 | awaiting T+20 | — | $25.77 (−1.23%) |
Aug 26, 2026 8w ago | 8-K | $26.66 $25.98 | ▼ −2.55% | ▼ −2.04% | $25.77 (−3.34%) |
Jul 8, 2026 15w ago | 8-K | $26.78 $26.72 | ▼ −0.22% | ▼ −3.50% | $25.77 (−3.77%) |
Jul 8, 2026 15w ago | 8-K | $26.78 $26.72 | ▼ −0.22% | ▼ −3.50% | $25.77 (−3.77%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers